BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 11784881)

  • 1. Lung cancer--time to move on from chemotherapy.
    Carney DN
    N Engl J Med; 2002 Jan; 346(2):126-8. PubMed ID: 11784881
    [No Abstract]   [Full Text] [Related]  

  • 2. [Irinotecan].
    Yokoyama A
    Nihon Rinsho; 2002 May; 60 Suppl 5():339-42. PubMed ID: 12101684
    [No Abstract]   [Full Text] [Related]  

  • 3. Randomized phase III trial of cisplatin/irinotecan versus cisplatin/etoposide in patients with extensive-stage small-cell lung cancer.
    Lara PN; Gandara DR; Natale RB
    Clin Lung Cancer; 2006 Mar; 7(5):353-6. PubMed ID: 16640809
    [No Abstract]   [Full Text] [Related]  

  • 4. [Chemotherapy for small cell lung cancer].
    Nakanishi Y; Uchino J
    Nihon Kokyuki Gakkai Zasshi; 2004 May; 42(5):399-403. PubMed ID: 15168456
    [No Abstract]   [Full Text] [Related]  

  • 5. Camptosar plus cisplatin increase survival in small-cell lung cancer study.
    Oncology (Williston Park); 2000 Sep; 14(9):1294. PubMed ID: 11033827
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of small cell lung cancer].
    Negoro S
    Gan To Kagaku Ryoho; 2005 Jun; 32(6):777-82. PubMed ID: 15984515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recent progress in the treatment of ED small cell lung cancer].
    Nokihara H; Ohe Y
    Nihon Rinsho; 2002 May; 60 Suppl 5():480-4. PubMed ID: 12101718
    [No Abstract]   [Full Text] [Related]  

  • 8. Can Carboplatin replace Cisplatin in small cell lung cancer?
    Noronha V
    Indian J Cancer; 2011; 48(4):452-3. PubMed ID: 22293259
    [No Abstract]   [Full Text] [Related]  

  • 9. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer.
    Noda K; Nishiwaki Y; Kawahara M; Negoro S; Sugiura T; Yokoyama A; Fukuoka M; Mori K; Watanabe K; Tamura T; Yamamoto S; Saijo N;
    N Engl J Med; 2002 Jan; 346(2):85-91. PubMed ID: 11784874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New state of the art in small-cell lung cancer.
    Tamura T
    Oncology (Williston Park); 2001 Jan; 15(1 Suppl 1):8-10. PubMed ID: 11221023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chemotherapy in lung cancer].
    Seto T
    Gan To Kagaku Ryoho; 2007 Aug; 34(8):1202-6. PubMed ID: 17847581
    [No Abstract]   [Full Text] [Related]  

  • 12. [Randomized controlled trials in Japan--lung cancer].
    Ichinose Y
    Gan To Kagaku Ryoho; 2002 Sep; 29(9):1516-21. PubMed ID: 12355937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of combination chemotherapy with cisplatin, vincristine, doxorubicin and etoposide (Tokushima-CODE: T-CODE) against lung cancer].
    Yanagawa H; Bando H; Takishita Y; Shinohara T; Tanaka H
    Gan To Kagaku Ryoho; 1992 Aug; 19(9):1403-5. PubMed ID: 1323959
    [No Abstract]   [Full Text] [Related]  

  • 14. Complement and correction for meta-analysis of patients with extensive-stage small cell lung cancer managed with irinotecan/cisplatin versus etoposide/cisplatin as first-line chemotherapy.
    Guo S; Liang Y; Zhou Q
    J Thorac Oncol; 2011 Feb; 6(2):406-8; author reply 408. PubMed ID: 21252725
    [No Abstract]   [Full Text] [Related]  

  • 15. [Current status of the chemotherapy for lung cancer].
    Tsuboi M; Kato H
    Gan To Kagaku Ryoho; 2002 May; 29(5):684-94. PubMed ID: 12040671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lung cancer].
    Ono A; Yamamoto N
    Gan To Kagaku Ryoho; 2007 Mar; 34(3):367-73. PubMed ID: 17353626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-dense therapy with a novel irinotecan regimen for small-cell lung cancer.
    Johnson FM; Kurie JM; Peeples BO; Pisters KM; Fossella FV; Papadimitrakopoulou VA; Blumenschein GR; Komaki R; Glisson BS
    Oncology (Williston Park); 2003 Jul; 17(7 Suppl 7):17-21. PubMed ID: 12886869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pilot study of concurrent etoposide and cisplatin plus accelerated hyperfractionated thoracic radiotherapy followed by irinotecan and cisplatin for limited-stage small cell lung cancer: Japan Clinical Oncology Group 9903.
    Kubota K; Nishiwaki Y; Sugiura T; Noda K; Mori K; Kawahara M; Negoro S; Watanabe K; Imamura F; Tamura T; Saijo N
    Clin Cancer Res; 2005 Aug; 11(15):5534-8. PubMed ID: 16061870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lung cancer with bone metastasis].
    Katakami N
    Gan To Kagaku Ryoho; 2006 Aug; 33(8):1049-53. PubMed ID: 16912519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemotherapy for lung cancer patients].
    Uramoto H; Kagami S; Iwashige A; Tsukada J
    J UOEH; 2006 Mar; 28(1):75-84. PubMed ID: 16541742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.